Why Do My Ears Feel Clogged? Understanding Eustachian Tube Dysfunction

Dr. Franklyn Gergits, ENT

Short answer: That persistent feeling of clogged ears, fullness, muffled hearing, or constant popping is almost always a Eustachian tube problem — not an ear problem. The Eustachian tube connects the middle ear to the back of the nasal cavity, and when it fails to open and close properly, pressure cannot equalize and the result is exactly what you are feeling. In most adults the cause traces upstream to allergy, chronic sinusitis, or laryngopharyngeal reflux driving inflammation at the tube’s nasopharyngeal opening. At the Sinus and Allergy Wellness Center of North Scottsdale, we evaluate and treat ETD in the same visit as sinus disease — because in most patients they share the same upstream driver. For patients who have not responded to medical management, in-office Eustachian tube balloon dilation under local anesthesia is a well-studied option with a 93.6 percent long-term responder rate.

What the Eustachian Tube Does — and Why It Matters

The Eustachian tube is a narrow channel — approximately 35 millimeters long in adults — that connects the middle ear space to the nasopharynx, the area at the very back of the nasal cavity. It serves three essential functions: pressure equalization between the middle ear and the environment, mucociliary clearance of secretions from the middle ear, and protection of the middle ear from pathogens and sound. When all three functions are working, the process is entirely silent and unnoticed. When the tube is dysfunctional, every one of those systems begins to fail simultaneously — and patients feel it as fullness, muffled hearing, popping, or a persistent sense that their ears will not clear.

ETD is far more common than most patients realize. It affects approximately one percent of the general population and over five percent of adults over 65. In the United States it accounts for more than two million adult hospital visits per year — making it one of the most prevalent and most undertreated conditions in ENT practice. Many patients spend years being told to take antihistamines or wait and see, never knowing that a specific structural intervention exists that directly addresses the tube itself.

Why ETD Almost Always Starts in the Nose

The Eustachian tube opens into the nasopharynx — directly adjacent to the posterior nasal cavity. This means that anything causing chronic inflammation, swelling, or dysfunction in the nasal cavity or nasopharynx can directly impair Eustachian tube function. ETD is not primarily an ear disease. It is an upstream airway disease that the ear experiences downstream. Treating the ear in isolation — without identifying and addressing the nasal driver — is why so many patients get only temporary or partial relief.

Allergy is strongly associated with ETD — patients with allergic rhinitis are more than twelve times as likely to develop middle ear dysfunction. In Scottsdale, Phoenix, and the greater Maricopa County area, the extended pollen season and year-round desert allergen burden mean that allergy-driven ETD can be persistent and chronic rather than seasonal. An important nuance for patients: while allergy is associated with ETD, treating it with intranasal corticosteroid sprays has limited direct efficacy for the ETD itself. A 2024 meta-analysis of randomized controlled trials found no significant tympanometric normalization with nasal steroid sprays compared to control, and systematic reviews show they are effective for chronic ETD in only 11 to 18 percent of cases. This does not mean allergy management is unimportant — it means that patients with persistent ETD despite allergy treatment should not simply be told to continue what is not working.

Chronic sinusitis and post-nasal drainage produce continuous mucus pooling in the nasopharynx that bathes the Eustachian tube opening and impairs its normal function. Population data shows that ETD patients are 4.2 times more likely to have chronic sinusitis than the general population. The upstream inflammation driving the sinus disease is almost always the same inflammation driving the ETD — which is why treating both conditions together, in the same visit, produces more complete and durable relief than treating each independently.

Laryngopharyngeal reflux is one of the most consistently overlooked drivers of ETD. Pepsin from the stomach reaching the nasopharynx causes mucosal injury directly at the Eustachian tube opening. Published data shows ETD patients have significantly more nasopharyngeal reflux events than controls — 2.3 versus 0.8 events per study period (p = 0.002) — with reflux finding scores nearly ten times higher (3.6 versus 0.4, p less than 0.001). Reflux symptom severity is independently predictive of poor Eustachian tube patency, and pepsin has been specifically implicated in Eustachian tube dysfunction at the cellular level. ETD patients are 2.4 times more likely to have GERD than the general population. For patients whose ETD does not respond to allergy treatment or sinus management, LPR is often the answer nobody has looked for.

Barometric pressure changes can acutely worsen ETD symptoms in patients whose tubes are already inflamed or dysfunctional. Flying, driving through elevation changes, and rapid weather shifts — especially pre-storm fronts — frequently trigger acute worsening in Scottsdale and Phoenix area patients. The Sonoran Desert’s significant elevation variation and monsoon weather patterns make this a clinically relevant pattern for our patient population.

How ETD Is Evaluated at SAWC

A complete ETD evaluation at the Sinus and Allergy Wellness Center of North Scottsdale includes nasal endoscopy to directly visualize the nasopharynx and the Eustachian tube openings, tympanometry to measure middle ear pressure and eardrum mobility, and audiometry to assess hearing. CT imaging of the sinuses is added when sinus disease is suspected as a contributing factor. Together these studies distinguish obstructive ETD — where the tube fails to open — from patulous ETD, where the tube stays open too much and produces an entirely different set of symptoms. This distinction is critical because the treatments are different, and balloon dilation is specifically indicated for obstructive ETD — not patulous ETD.

The AAO-HNS 2019 Clinical Consensus Statement on Eustachian tube balloon dilation specifies that the diagnosis of obstructive ETD should not be made without comprehensive assessment including otoscopy, audiometry, and nasal endoscopy. That is exactly the standard we apply.

Medical Management — What to Try First

For patients presenting with ETD for the first time or without prior evaluation, medical management is the appropriate starting point. Nasal saline irrigation twice daily, daily intranasal corticosteroid spray, and treatment of underlying allergy or reflux address the upstream drivers that impair Eustachian tube function. Auto-inflation techniques — Valsalva maneuver, or specialized devices like the Otovent — can temporarily open the tube and equalize pressure, providing short-term symptom relief.

Patients should understand, however, that the published evidence for medical therapy in chronic ETD is modest. Only about half of patients experience meaningful improvement with medical management alone, and nasal steroid sprays — the most commonly recommended medical therapy — show limited efficacy in chronic cases. This is not a reason to skip medical management. It is a reason to have an honest conversation about realistic expectations and to establish a clear threshold for when procedural evaluation becomes appropriate.

Eustachian Tube Balloon Dilation — The Structural Solution

For patients whose ETD has not responded adequately to medical management, Eustachian tube balloon dilation is the procedural option recognized by the AAO-HNS 2019 Clinical Consensus Statement as “an option for treatment of patients with obstructive ETD.” A small flexible balloon catheter is passed through the nostril under direct visualization and positioned at the Eustachian tube opening. The balloon is inflated for a defined interval — dilating the tube, creating controlled microfractures in the cartilaginous framework, and remodeling the mucosal tissue in a way that allows the tube to hold open more reliably. The balloon is then deflated and removed. No incisions. No tissue excision. Same-day return to activity.

The long-term outcome data is compelling. A prospective randomized controlled trial showed normalization of validated ETD symptom scores in 56.2 percent of dilation patients versus 8.5 percent of controls at six weeks (p less than 0.001). At a mean follow-up of 29.4 months, 93.6 percent of patients achieved clinically meaningful symptom improvement, the revision rate was only 2.1 percent, and patient satisfaction was 83 percent. A multicenter cohort of 248 patients showed significant improvement sustained at 24 months across all patient subtypes — with the greatest benefit seen in patients whose ETD is triggered by altitude and pressure changes, which is particularly relevant for patients in the Phoenix and Scottsdale area given the frequency of air travel and the region’s elevation profile.

At SAWC, Eustachian tube dilation is performed in the office under local anesthesia — no hospital, no general anesthesia, same-day return to activity. It is frequently performed at the same visit as balloon sinuplasty when both conditions are present, since the upstream inflammation driving sinus disease is almost always the same inflammation driving the ETD. For a complete clinical explanation of exactly what happens during the procedure, the recovery timeline, and what durable results look like — see our full post on Eustachian tube dilation on the Airway & Sinus Wellness Review.

When to Seek Immediate Evaluation

Most ETD is uncomfortable but not urgent. However, sudden hearing loss — any significant drop in hearing that comes on over hours to days — requires same-day or next-day evaluation, as it can represent a separate condition requiring prompt treatment. Ear pain accompanied by high fever, drainage from the ear canal, or significant dizziness with ear symptoms also warrants prompt evaluation rather than watchful waiting.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ What Eustachian Tube Dilation Actually Does — The Complete Clinical Guide

→ Why Antibiotics Keep Failing Your Sinus Infection

→ Will Balloon Sinuplasty Correct My Post-Nasal Drainage?

→ Does Balloon Sinuplasty Actually Work?

→ Airway & Sinus Wellness Review — Full Publication

This post is part of the Understanding Your Symptoms section of the Airway & Sinus Wellness Review.

References

1. Huisman JML, et al. Cochrane review: Eustachian tube balloon dilation for obstructive ETD. 2025. ~1% general population prevalence; 35mm length; three primary functions; >2 million US adult hospital visits/year.

2. SEER-Medicare database analysis. ETD patients 4.20x more likely to have chronic sinusitis (OR 4.20, 95% CI 3.98–4.43); 2.42x more likely to have GERD (OR 2.42, 95% CI 2.31–2.53); prevalence 5.44% in US adults over 65.

3. Poe DS, et al. Randomized controlled trial: ETDQ-7 normalization 56.2% vs. 8.5% at 6 weeks (p<0.001). AAO-HNS 2019 Clinical Consensus Statement: BDET is “an option for treatment of patients with OETD”; diagnosis requires otoscopy, audiometry, nasal endoscopy.

4. Cutler JL, et al. Long-term balloon ETD outcomes: 93.6% responder rate; 2.1% revision rate; 83% patient satisfaction at mean 29.4 months follow-up. 2019.

5. Sandoval multicenter cohort. 248 patients, 319 ears. Significant improvement sustained at 24 months; greatest benefit in baro-challenge patients; >80% avoidance of repeat tube insertion.

6. 2024 meta-analysis of INCS for ETD. No significant tympanometric normalization with INCS vs. control (OR 1.21, 95% CI 0.65–2.24); effective in only 11–18% of chronic ETD cases.

7. Brunworth JD, et al. LPR-ETD: nasopharyngeal reflux events 2.3 vs. 0.8 (p=0.002); reflux finding scores 3.6 vs. 0.4 (p<0.001); pepsin specifically implicated in ET dysfunction. 2014.

8. Mendelian randomization study. Causal link between allergic rhinitis and nonsuppurative otitis media (OR 12.22, p=0.024).

9. Piccirillo JF, Payne SC, Rosenfeld RM, et al. Clinical Practice Guideline: Adult Sinusitis Update. Otolaryngology–Head and Neck Surgery. 2025. entnet.org

10. Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. Journal of Allergy and Clinical Immunology. 2020.

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, submucosal partial inferior turbinectomy, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you have persistent ear fullness, muffled hearing, or ear popping that has not responded to standard treatment, consult with a qualified otolaryngologist for a complete evaluation including tympanometry and nasal endoscopy.